Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE.
Afya stock snapshot and recent performance
Afya (NasdaqGS:AFYA) trades around $14.01, with the stock roughly flat over the past week and modestly higher over the past month. Over the past 3 months, the stock has delivered a stronger positive return.
See our latest analysis for Afya.
While the share price has edged up over the past 3 months, the year to date share price return is down 6.29%, and the 1 year total shareholder return has declined 21.00%. This means recent momentum is modest compared with longer term mixed results.
If Afya has you rethinking where growth could come from next, it might be worth scanning for other education and services peers using a broader founder led companies screener such as 20 top founder-led companies
With Afya trading around $14.01 and carrying an indicated discount to some valuation estimates, the key question now is simple: is the stock still undervalued, or is the market already pricing in its future growth?
Most Popular Narrative: 18.2% Undervalued
The most followed narrative currently sees Afya's fair value at $17.14, compared with the last close of $14.01. This frames the stock as meaningfully discounted and puts the focus squarely on the durability of its medical education model.
The company's focus on operational efficiencies (including centralized shared services and cost controls across all segments) is expected to continue driving SG&A expense dilution and margin expansion, enhancing future net income and free cash flow.
Want to see what is baked into that fair value? Revenue, earnings and margins are all carefully wired into one projection. The profit assumptions may surprise you.
Result: Fair Value of $17.14 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this depends on Afya managing rising competition for medical students and potential pressure from higher, less predictable effective tax rates in Brazil.
Find out about the key risks to this Afya narrative.
Next Steps
Unsure whether the current mix of concerns and optimism around Afya matches your own view? You can take a closer look at the trade off between risks and rewards through 5 key rewards and 1 important warning sign
Looking for more investment ideas?
If Afya has your attention, do not stop here. Use the screener to uncover other stocks that fit your style before the next opportunity slips past.
-
Target potential upside with companies that screen as attractively priced on quality, value and fundamentals through 46 high quality undervalued stocks
-
Strengthen your defensive core by focusing on resilient businesses highlighted in the 64 resilient stocks with low risk scores
-
Hunt for under the radar opportunities with strong financials using the screener containing 22 high quality undiscovered gems
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include AFYA .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
